Canada markets closed

Cell MedX Corp. (CMXC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0300+0.0080 (+36.36%)
At close: 11:45AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-05-31
2022-05-31
2021-05-31
2020-05-31
Total Revenue
0.074
2.762
6.065
6.762
95.824
Cost of Revenue
0.545
2.279
2.032
3.24
10.236
Gross Profit
-0.471
0.483
4.033
3.522
85.588
Operating Expenses
Research Development
-20.053
89.22
150.709
229.581
393.216
Selling General and Administrative
235.746
358.921
523.872
454.094
728.877
Total Operating Expenses
215.693
448.141
675.726
686.109
1,124
Operating Income or Loss
-216.164
-447.658
-671.693
-682.587
-1,038
Interest Expense
-
-
-
-
21.069
Total Other Income/Expenses Net
-
-
-
-196.229
-33.278
Income Before Tax
-96.912
-495.042
-697.379
-910.836
-1,093
Income from Continuing Operations
-96.912
-495.042
-697.379
-910.836
-1,093
Net Income
-96.912
-495.042
-697.379
-910.836
-1,093
Net Income available to common shareholders
-96.912
-495.042
-697.379
-910.836
-1,093
Basic EPS
-0.01
-0.01
-0.01
-0.02
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.02
-0.02
Basic Average Shares
62,923
62,923
62,799
58,764
53,478
Diluted Average Shares
62,923
62,923
62,799
58,764
53,478